Your browser doesn't support javascript.
loading
The Effect of SMN Gene Dosage on ALS Risk and Disease Severity.
Moisse, Matthieu; Zwamborn, Ramona A J; van Vugt, Joke; van der Spek, Rick; van Rheenen, Wouter; Kenna, Brendan; Van Eijk, Kristel; Kenna, Kevin; Corcia, Philippe; Couratier, Philippe; Vourc'h, Patrick; Hardiman, Orla; McLaughin, Russell; Gotkine, Marc; Drory, Vivian; Ticozzi, Nicola; Silani, Vincenzo; de Carvalho, Mamede; Mora Pardina, Jesús S; Povedano, Monica; Andersen, Peter M; Weber, Markus; Basak, Nazli A; Chen, Xiao; Eberle, Michael A; Al-Chalabi, Ammar; Shaw, Chris; Shaw, Pamela J; Morrison, Karen E; Landers, John E; Glass, Jonathan D; Robberecht, Wim; van Es, Michael; van den Berg, Leonard; Veldink, Jan; Van Damme, Philip.
Affiliation
  • Moisse M; Departments of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.
  • Zwamborn RAJ; Laboratory of Neurobiology, VIB, Center for Brain and Disease Research, Leuven, Belgium.
  • van Vugt J; Department of Neurology, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
  • van der Spek R; Department of Neurology, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
  • van Rheenen W; Department of Neurology, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
  • Kenna B; Department of Neurology, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
  • Van Eijk K; Department of Neurology, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
  • Kenna K; Department of Neurology, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
  • Corcia P; Department of Neurology, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
  • Couratier P; Centre SLA, CHRU de Tours, Tours, France.
  • Vourc'h P; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.
  • Hardiman O; Centre SLA, CHRU de Tours, Tours, France.
  • McLaughin R; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.
  • Gotkine M; Academic Unit of Neurology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Republic of Ireland.
  • Drory V; Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Republic of Ireland.
  • Ticozzi N; The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Silani V; Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.
  • de Carvalho M; Department of Neurology, Stroke Unit and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.
  • Mora Pardina JS; Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milan, Italy.
  • Povedano M; Department of Neurology, Stroke Unit and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.
  • Andersen PM; Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milan, Italy.
  • Weber M; Instituto de Fisiologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Basak NA; ALS Unit, Hospital San Rafael, Madrid, Spain.
  • Chen X; Servei de Neurologia, HUB-IDIBELL, Barcelona, Spain.
  • Eberle MA; Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.
  • Al-Chalabi A; Neuromuscular Diseases Unit/ALS Clinic, St. Gallen, Switzerland.
  • Shaw C; Koç University, School of Medicine, KUTTAM-NDAL, Istanbul, Turkey.
  • Shaw PJ; Illumina Inc., San Diego, CA.
  • Morrison KE; Illumina Inc., San Diego, CA.
  • Landers JE; Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
  • Glass JD; Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
  • Robberecht W; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.
  • van Es M; School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • van den Berg L; Department of Neurology, University of Massachusetts Medical School, Worcester, MA.
  • Veldink J; Department Neurology, Emory University School of Medicine, Atlanta, GA.
  • Van Damme P; Departments of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.
Ann Neurol ; 89(4): 686-697, 2021 04.
Article in En | MEDLINE | ID: mdl-33389754
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Survival of Motor Neuron 1 Protein / Amyotrophic Lateral Sclerosis Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Ann Neurol Year: 2021 Document type: Article Affiliation country: Belgium Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Survival of Motor Neuron 1 Protein / Amyotrophic Lateral Sclerosis Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Ann Neurol Year: 2021 Document type: Article Affiliation country: Belgium Country of publication: United States